CDMO Selection for Small Molecule vs Biologics | Help Center | CDMO Hub

CDMO Selection for Small Molecule vs Biologics

Understanding the key differences when selecting CDMOs for small molecule versus biologic drug development.

CDMO Selection1 min readUpdated 2025-09-05911 views

CDMO Selection for Small Molecule vs Biologics

Small Molecule Considerations

Manufacturing Complexity

Chemical synthesis routes
Impurity profiles
Stability requirements

Equipment Requirements

Reactors and process equipment
Purification systems
Solid dosage capabilities

Biologics Considerations

Manufacturing Complexity

Cell line development
Upstream/downstream processing
Analytical characterization

Specialized Capabilities

Cell culture expertise
Chromatography systems
Cold chain logistics

Comparison Framework

Criteria	Small Molecule	Biologics
Scale-up	Linear	Non-linear
Timeline	12-18 months	18-36 months
Cost	Lower	Higher
Regulatory	Well-established	Evolving

Did this answer your question?

Still stuck? Contact support